Skip to main content
Erschienen in: Journal of Inherited Metabolic Disease 3/2010

01.06.2010 | Images in Metabolic Medicine

Lysosomal lipid vacuoles in macrophages located in the colon

verfasst von: Wouter Meersseman, Steven Vanderschueren, Rita De Vos, David Cassiman

Erschienen in: Journal of Inherited Metabolic Disease | Ausgabe 3/2010

Einloggen, um Zugang zu erhalten

Excerpt

A 22-year old female patient presented with abdominal pain, diarrhea, and a history of tonsillectomy. Ultrasound showed an enlarged spleen with a diameter of 13 cm. There was no hepatomegaly or peripheral neuropathy. Lab results were remarkable for a low high-density lipoprotein (HDL) cholesterol level (3 mg/dl, normal ≥40 mg/dl). A sigmoidoscopy showed yellowish lesions. Light microscopy showed foam-cell disposition in the submucosal layers. Electron microscopy revealed lysosomal lipid vacuoles and crystalline cholesterol clefts in the cytoplasm of macrophages (see Fig. 1). Other sites of foam-cell deposition were found in biopsies from the gastric mucosa. Apolipoprotein A1 (apo-A1) level was <0.1 g/l (normal 1.08–2.25 g/l). A homozygous mutation C342T near exon 22 was found, resulting in a stop codon at the glutamine level in position 1038. This leads to a deficiency in ABCA1, an adenosine triphosphate (ATP)-binding cassette transporter, which suggests a diagnosis of Tangier’s disease. Under normal circumstances, this plasma membrane protein has been shown to mediate cholesterol efflux to nascent, apo-A1-rich HDL particles (Brewer et al. 2004). The lack of cholesterol efflux by the deficient ABCA 1 to nascent HDL increases catabolism of this lipid-poor HDL particle (Remaley et al. 1997). The characteristic clinical findings include the presence of enlarged yellow tonsils, splenomegaly, and peripheral neuropathy. Other sites of foam-cell deposition include bone marrow and rectum. In view of a low HDL cholesterol, Tangier’s disease is one disease that needs to be suspected (Breslow 2000). Other causes of low HDL cholesterol are lecithin-cholesterol acyltransferase (LCAT) deficiency, familial HDL deficiency, and some of the sphingolipidoses. Tangier’s disease can manifest in the gastrointestinal tract. There is need for search for this disease because patients are at risk for atherosclerotic complications. They can benefit from lipid-lowering drugs and general lifestyle modifications.
Literatur
Zurück zum Zitat Breslow JL (2000) Genetics of lipoprotein abnormalities associated with coronary artery disease susceptibility. Annu Rev Genet 34:233–254CrossRefPubMed Breslow JL (2000) Genetics of lipoprotein abnormalities associated with coronary artery disease susceptibility. Annu Rev Genet 34:233–254CrossRefPubMed
Zurück zum Zitat Brewer HB, Remaley AT, Neufeld EB et al (2004) Regulation of plasma high-density lipoprotein levels by the ABCA1 transporter and the emerging role of high-density lipoprotein in the treatment of cardiovascular disease. Arterioscler Thromb Vasc Biol 24:1755–1760CrossRefPubMed Brewer HB, Remaley AT, Neufeld EB et al (2004) Regulation of plasma high-density lipoprotein levels by the ABCA1 transporter and the emerging role of high-density lipoprotein in the treatment of cardiovascular disease. Arterioscler Thromb Vasc Biol 24:1755–1760CrossRefPubMed
Zurück zum Zitat Remaley AT, Schumacher UK, Stonik JA et al (1997) Decreased reverse cholesterol transport from Tangier disease fibroblasts. Acceptor specificity and effect of brefeldin on lipid efflux. Arterioscler Thromb Vasc Biol 17:1813–1821PubMed Remaley AT, Schumacher UK, Stonik JA et al (1997) Decreased reverse cholesterol transport from Tangier disease fibroblasts. Acceptor specificity and effect of brefeldin on lipid efflux. Arterioscler Thromb Vasc Biol 17:1813–1821PubMed
Metadaten
Titel
Lysosomal lipid vacuoles in macrophages located in the colon
verfasst von
Wouter Meersseman
Steven Vanderschueren
Rita De Vos
David Cassiman
Publikationsdatum
01.06.2010
Verlag
Springer Netherlands
Erschienen in
Journal of Inherited Metabolic Disease / Ausgabe 3/2010
Print ISSN: 0141-8955
Elektronische ISSN: 1573-2665
DOI
https://doi.org/10.1007/s10545-010-9110-x

Weitere Artikel der Ausgabe 3/2010

Journal of Inherited Metabolic Disease 3/2010 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.